- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-4681
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Mixed Response to Immunotherapy in Patients with Metastatic Melanoma ; day:29 ; month:5 ; year:2020 ; pages:1-10
Annals of surgical oncology ; (29.5.2020), 1-10
- Creator
-
Rauwerdink, Daan Jan Willem
Molina, George
Frederick, Dennie Tompers
Sharova, Tanya
Hage, Jos van der
Cohen, Sonia
Boland, Genevieve Marie
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1245/s10434-020-08657-6
- URN
-
urn:nbn:de:101:1-2020080217250200359550
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rauwerdink, Daan Jan Willem
- Molina, George
- Frederick, Dennie Tompers
- Sharova, Tanya
- Hage, Jos van der
- Cohen, Sonia
- Boland, Genevieve Marie
- SpringerLink (Online service)
Other Objects (12)
Predicting response to immunotherapy in metastatic melanoma by a personalized mathematical model
Immunotherapy for metastatic melanoma—from little benefit to first-line treatment
Modulation of the Gut Microbiome to Enhance Immunotherapy Response in Metastatic Melanoma Patients: A Clinical Review
Can physiologic colonic [18F]FDG uptake in PET/CT imaging predict response to immunotherapy in metastatic melanoma?
Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma
Immunotherapy of malignant melanoma
Metastatic Ductal Eccrine Adenocarcinoma with Excellent Response to Immunotherapy
Multiplex quantitative analysis of cancer-associated fibroblasts and immunotherapy outcome in metastatic melanoma
Rapid complete response of metastatic melanoma in a patient undergoing ipilimumab immunotherapy in the setting of active ulcerative colitis
Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma
Multi-scale geometric network analysis identifies melanoma immunotherapy response gene modules
METASTATIC MALIGNANT MELANOMA OF SKIN
Predicting response to immunotherapy in metastatic melanoma by a personalized mathematical model
Immunotherapy for metastatic melanoma—from little benefit to first-line treatment
Modulation of the Gut Microbiome to Enhance Immunotherapy Response in Metastatic Melanoma Patients: A Clinical Review
Can physiologic colonic [18F]FDG uptake in PET/CT imaging predict response to immunotherapy in metastatic melanoma?
Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma
Immunotherapy of malignant melanoma
Metastatic Ductal Eccrine Adenocarcinoma with Excellent Response to Immunotherapy
Multiplex quantitative analysis of cancer-associated fibroblasts and immunotherapy outcome in metastatic melanoma
Rapid complete response of metastatic melanoma in a patient undergoing ipilimumab immunotherapy in the setting of active ulcerative colitis
Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma
Multi-scale geometric network analysis identifies melanoma immunotherapy response gene modules
METASTATIC MALIGNANT MELANOMA OF SKIN
Predicting response to immunotherapy in metastatic melanoma by a personalized mathematical model
Immunotherapy for metastatic melanoma—from little benefit to first-line treatment
Modulation of the Gut Microbiome to Enhance Immunotherapy Response in Metastatic Melanoma Patients: A Clinical Review
Can physiologic colonic [18F]FDG uptake in PET/CT imaging predict response to immunotherapy in metastatic melanoma?
Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma
Immunotherapy of malignant melanoma
Metastatic Ductal Eccrine Adenocarcinoma with Excellent Response to Immunotherapy
Multiplex quantitative analysis of cancer-associated fibroblasts and immunotherapy outcome in metastatic melanoma
Rapid complete response of metastatic melanoma in a patient undergoing ipilimumab immunotherapy in the setting of active ulcerative colitis
Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma
Multi-scale geometric network analysis identifies melanoma immunotherapy response gene modules